Development of Synthesis Technology and Quality Control for the Immunotropic Agent Kemantane


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

A new technology for synthesis of the immunomodulator drug Kemantane was developed.

Sobre autores

N. Avdyunina

V. V. Zakusov Science Research Institute of Pharmacology

Email: chem@folium.ru
Rússia, 8 Baltiiskaya Street, Moscow, 125315

A. Tolkacheva

V. V. Zakusov Science Research Institute of Pharmacology; I. M. Sechenov First Moscow State Medical University

Email: chem@folium.ru
Rússia, 8 Baltiiskaya Street, Moscow, 125315; Building 8, 2 Trubetskaya Street, Moscow, 119991

L. Grushevskaya

V. V. Zakusov Science Research Institute of Pharmacology

Email: chem@folium.ru
Rússia, 8 Baltiiskaya Street, Moscow, 125315

B. Pyatin

V. V. Zakusov Science Research Institute of Pharmacology

Email: chem@folium.ru
Rússia, 8 Baltiiskaya Street, Moscow, 125315

R. Bol’shakova

V. V. Zakusov Science Research Institute of Pharmacology

Email: chem@folium.ru
Rússia, 8 Baltiiskaya Street, Moscow, 125315

N. Zaitseva

V. V. Zakusov Science Research Institute of Pharmacology

Email: chem@folium.ru
Rússia, 8 Baltiiskaya Street, Moscow, 125315

M. Ustinova

V. V. Zakusov Science Research Institute of Pharmacology

Email: chem@folium.ru
Rússia, 8 Baltiiskaya Street, Moscow, 125315

V. Prokof’eva

I. M. Sechenov First Moscow State Medical University

Email: chem@folium.ru
Rússia, Building 8, 2 Trubetskaya Street, Moscow, 119991

L. Gaevaya

V. V. Zakusov Science Research Institute of Pharmacology

Email: chem@folium.ru
Rússia, 8 Baltiiskaya Street, Moscow, 125315

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media New York, 2016